Literature DB >> 29635851

Brain PET substrate of impulse control disorders in Parkinson's disease: A metabolic connectivity study.

Antoine Verger1,2,3, Elsa Klesse4,5, Mohammad B Chawki2, Tatiana Witjas4,5, Jean-Philippe Azulay4,5, Alexandre Eusebio4,5, Eric Guedj1,5,6.   

Abstract

Impulse control disorders (ICDs) have received increased attention in Parkinson's disease (PD) because of potentially dramatic consequences. Their physiopathology, however, remains incompletely understood. An overstimulation of the mesocorticolimbic system has been reported, while a larger network has recently been suggested. The aim of this study is to specifically describe the metabolic PET substrate and related connectivity changes in PD patients with ICDs. Eighteen PD patients with ICDs and 18 PD patients without ICDs were evaluated using cerebral 18F-fluorodeoxyglucose positron emission tomography. SPM-T maps comparisons were performed between groups and metabolic connectivity was evaluated by interregional correlation analysis (IRCA; p < .005, uncorrected; k > 130) and by graph theory (p < .05). PD patients with ICDs had relative increased metabolism in the right middle and inferior temporal gyri compared to those without ICDs. The connectivity of this area was increased mostly with the mesocorticolimbic system, positively with the orbitofrontal region, and negatively with both the right parahippocampus and the left caudate (IRCA). Moreover, the betweenness centrality of this area with the mesocorticolimbic system was lost in patients with ICDs (graph analysis). ICDs are associated in PD with the dysfunction of a network exceeding the mesocorticolimbic system, and especially the caudate, the parahippocampus, and the orbitofrontal cortex, remotely including the right middle and inferior temporal gyri. This latest area loses its central place with the mesocorticolimbic system through a connectivity dysregulation.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  FDG-PET; Parkinson's disease; impulse control disorders; metabolic connectivity

Mesh:

Substances:

Year:  2018        PMID: 29635851      PMCID: PMC6866256          DOI: 10.1002/hbm.24068

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  42 in total

Review 1.  Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

Authors:  G L Defer; H Widner; R M Marié; P Rémy; M Levivier
Journal:  Mov Disord       Date:  1999-07       Impact factor: 10.338

2.  Evidence for cortical encoding specificity in episodic memory: memory-induced re-activation of picture processing areas.

Authors:  Chandan J Vaidya; Margaret Zhao; John E Desmond; John D E Gabrieli
Journal:  Neuropsychologia       Date:  2002       Impact factor: 3.139

3.  Distorted expectancy coding in problem gambling: is the addictive in the anticipation?

Authors:  Ruth J van Holst; Dick J Veltman; Christian Büchel; Wim van den Brink; Anna E Goudriaan
Journal:  Biol Psychiatry       Date:  2012-02-18       Impact factor: 13.382

4.  Resting-state brain networks in patients with Parkinson's disease and impulse control disorders.

Authors:  Alessandro Tessitore; Gabriella Santangelo; Rosa De Micco; Alfonso Giordano; Simona Raimo; Marianna Amboni; Fabrizio Esposito; Paolo Barone; Gioacchino Tedeschi; Carmine Vitale
Journal:  Cortex       Date:  2017-06-24       Impact factor: 4.027

5.  Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery.

Authors:  Michael N Smolka; Mira Bühler; Sabine Klein; Ulrich Zimmermann; Karl Mann; Andreas Heinz; Dieter F Braus
Journal:  Psychopharmacology (Berl)       Date:  2005-08-13       Impact factor: 4.530

6.  Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.

Authors:  G Giovannoni; J D O'Sullivan; K Turner; A J Manson; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

7.  Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's disease.

Authors:  Joana B Pereira; Dag Aarsland; Cedric E Ginestet; Alexander V Lebedev; Lars-Olof Wahlund; Andrew Simmons; Giovanni Volpe; Eric Westman
Journal:  Hum Brain Mapp       Date:  2015-05-06       Impact factor: 5.038

8.  Metabolic connectivity by interregional correlation analysis using statistical parametric mapping (SPM) and FDG brain PET; methodological development and patterns of metabolic connectivity in adults.

Authors:  Dong Soo Lee; Hyejin Kang; Heejung Kim; Hyojin Park; Jungsu S Oh; Jae Sung Lee; Myung Chul Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-20       Impact factor: 9.236

9.  BOLD responses reflecting dopaminergic signals in the human ventral tegmental area.

Authors:  Kimberlee D'Ardenne; Samuel M McClure; Leigh E Nystrom; Jonathan D Cohen
Journal:  Science       Date:  2008-02-29       Impact factor: 47.728

10.  Multiple modes of impulsivity in Parkinson's disease.

Authors:  Cristina Nombela; Timothy Rittman; Trevor W Robbins; James B Rowe
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more
  12 in total

1.  Molecular imaging of impulse control disorders in Parkinson's disease.

Authors:  Joonas Majuri; Juho Joutsa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-31       Impact factor: 9.236

2.  The renaissance of functional 18F-FDG PET brain activation imaging.

Authors:  Antoine Verger; Eric Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-29       Impact factor: 9.236

3.  Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.

Authors:  I Navalpotro-Gomez; R Dacosta-Aguayo; F Molinet-Dronda; A Martin-Bastida; A Botas-Peñin; H Jimenez-Urbieta; M Delgado-Alvarado; B Gago; A Quiroga-Varela; Maria C Rodriguez-Oroz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-04       Impact factor: 9.236

Review 4.  Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.

Authors:  Cecilia Peralta; Federico Biafore; Tamara Soto Depetris; Maria Bastianello
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-29       Impact factor: 5.081

5.  From metabolic connectivity to molecular connectivity: application to dopaminergic pathways.

Authors:  Antoine Verger; Tatiana Horowitz; Mohammad B Chawki; Alexandre Eusebio; Manon Bordonne; Jean-Philippe Azulay; Nadine Girard; Eric Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-18       Impact factor: 9.236

6.  Brain PET substrate of impulse control disorders in Parkinson's disease: A metabolic connectivity study.

Authors:  Antoine Verger; Elsa Klesse; Mohammad B Chawki; Tatiana Witjas; Jean-Philippe Azulay; Alexandre Eusebio; Eric Guedj
Journal:  Hum Brain Mapp       Date:  2018-04-10       Impact factor: 5.038

7.  [Changes of brain structural network properties in patients with rapid eye movement sleep behavior disorder].

Authors:  Ruirui Zhang; Zhonglin Li; Yingying Bai; Pengfei Xu; Jiewen Zhang; Hongju Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

8.  Effects of subthalamic deep brain stimulation on striatal metabolic connectivity in a rat hemiparkinsonian model.

Authors:  Nadine Apetz; Elena Kordys; Mascha Simon; Britta Mang; Markus Aswendt; Dirk Wiedermann; Bernd Neumaier; Alexander Drzezga; Lars Timmermann; Heike Endepols
Journal:  Dis Model Mech       Date:  2019-05-24       Impact factor: 5.758

Review 9.  Brain Imaging and Impulse Control Disorders in Parkinson's Disease.

Authors:  Andreas-Antonios Roussakis; Nicholas P Lao-Kaim; Paola Piccini
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-08       Impact factor: 5.081

10.  Impulse Control Disorders in Parkinson's Disease. A Brief and Comprehensive Review.

Authors:  Emilia M Gatto; Victoria Aldinio
Journal:  Front Neurol       Date:  2019-04-17       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.